Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label, 2-arm study in which patients are randomized to receive either the
formulation that is being used in clinical trials or the formulation that will be used when
if the drug becomes commercially available. The purpose of this study is to compare the
pharmacokinetics of the two formulations.